Buyout (LBO, MBO, MBI) • Life Science

Cinven Acquires Amdipharm Mercury Co. - AMCo.

On October 15, 2012, private equity firm Cinven acquired life science company Amdipharm Mercury Co. - AMCo. for 367M GBP

Acquisition Context
  • This is Cinven’s 4th transaction in the Life Science sector.
  • This is Cinven’s 46th largest (disclosed) transaction.
  • This is Cinven’s 76th transaction in the United Kingdom.
Investment Fate
  • Amdipharm Mercury Co. - AMCo. was sold to a publicly-traded strategic buyer in 2015 for 3.5B USD.

Explore All 460 Buyout (LBO, MBO, MBI) Life Science Deals - Search the Database Free


M&A Deal Summary

Date October 15, 2012
Target Amdipharm Mercury Co. - AMCo.
Sector Life Science
Buyer(s) Cinven
Deal Type Buyout (LBO, MBO, MBI)
Deal Value 367M GBP

Target Company

Amdipharm Mercury Co. - AMCo.

Croydon, United Kingdom
Amdipharm Mercury (AMCo) is an international speciality pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Cinven

London, United Kingdom

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1977
PE ASSETS 39.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Cinven is a private equity firm focused on buyout investments in growing, profitable businesses located throughout Europe and North America. Sectors of interest include business and financial services, healthcare, industrial, retail, leisure, consumer, technology, media, and telecommunications. Cinven looks to invest a minimum of €200 million in companies with minimum enterprise values of €400 million. Cinven does not invest in start-ups or development phase companies. Cinven was established in 1977 and is headquartered in London.


Deal Context for Buyer #
Overall 128 of 186
Sector: Life Science 4 of 8
Type: Buyout (LBO, MBO, MBI) 70 of 77
Country: United Kingdom 76 of 88
Year: 2012 5 of 5
Size (of disclosed) 46 of 62
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-08-17 Mercury Pharma Group

Surrey, United Kingdom

Mercury Pharma Group is an international specialty pharmaceutical company selling niche prescription pharmaceuticals. The company markets its products across the globe with primary focus in UK and EU markets and operational bases in the UK, Ireland and India. Mercury Pharma Group was founded in 1991 and is based in Surrey, United Kingdom.

Buy £465M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-01 Partnership Assurance

London, United Kingdom

Partnership Assurance Ltd. is a specialist provider of retirement solutions. The company provides insurance products to individuals who, because of an existing medical condition, have a reduced life expectancy and hence qualify for a higher or enhanced retirement annuity.

Sell -